Fully Integrated Marketing & Communications
Amplifying Scientific Innovation
Creating Value via Scientific Storytelling
Amplifying Scientific Innovation
Established in New York City, The Sophia Consulting Firm is a fully integrated marketing and communications firm with a specialty focus on oncology.
The firm partners with US and non-US emerging and established life science and healthcare technology companies to amplify scientific innovation, increase corporate visibility and attract investors.
The Sophia Consulting firm empowers client partners with integrated corporate and product communications support for clinical-stage assets through seamless provision of public relations, scientific communications, market research and strategic marketing services. These services are uniquely designed to evolve the corporate narrative for client partners and to identify white space opportunities.
In addition, The Sophia Consulting Firm sponsors the Amplifying Scientific Innovation Podcast, which showcases new scientific discoveries stemming from global life science companies with an emphasis on emerging biotechnology companies.
Developing Credible Content
Public Relations & Scientific Communications
Create and showcase credible scientific content rooted in data-driven research techniques to attract investors and increase corporate visibility via:
- Live coverage of scientific/ industry conferences
- Onsite congress support
- Scientific communications platforms
- Disease state education
- Mechanism of action (MOA) video production
- Social media content development & rollout
- Financial/Investor communications
- Media outreach/engagement
- Spokesperson media training
- Advisory board planning
Partnering with Thought Leaders
Market Research & Strategic Marketing
Engage with US and/or global senior executives, thought leaders, medical experts, hospital stakeholders and investors with the goal of increasing scientific credibility and stakeholder buy-in via:
- Strategic planning
- Value communications
- Market access (pricing & reimbursement)
- Medical expert (KOL) identification & engagement
- Expert Interviews (hospital stakeholders, industry executives)
- Competitive intelligence
- Commercial due diligence
Maximizing Impact & Message Reach
In oncology and hematology, we have supported client partners with innovative work in:
- CAR T cell therapies (BCMA, CD19)
- Cytotoxic T-cells
- Epigenetics
- PI3K Inhibitors
- Checkpoint inhibitors
- Antibody-drug conjugates (ADCs)
- Combination therapies
- Immuno-oncology
The firm also provides consulting services in diverse therapeutic areas including:
- Mental health
- Rare diseases
- Stem cell & regenerative medicine
- Dermatology & aesthetic medicine
- Women's health
- Pain management
Curating Purpose-driven Teams
We partner with world-class talent on a per-project basis with the goal of optimizing client satisfaction by right-sizing teams. Our partners include:
- Medical experts
- Venture capital firms
- Investment banks
- Legal & regulatory partners
- PR & IR professionals
- Scientific animation producers
- Graphic designers
We hold ourselves to the highest standards and leverage relevant trends in order to develop actionable insights that stand the test of time. We are:
- Passionate about science
- Dedicated to the pursuit of excellence
- Focused on the things that matter
Curious about new science?
Tune In to Learn About New Scientific Discoveries
The Amplifying Scientific Innovation Podcast showcases scientific innovation stemming from global life science companies from the perspective of CEOs and senior executives who are developing transformative, lifesaving solutions for patients.
Listen on SoundCloud, Spotify, Anchor, Google, Apple, Amazon and iHeartRadio.
Featured On
About Founder & CEO, Dr. Sophia Ononye-Onyia
Multidisciplinary Background
BS Honors, Biochemistry, BGSU
MPH, Public Health Administration, UTOLEDO
MBA, Healthcare Administration, UCONN
PhD, Medicinal Chemistry, UCONN
Advanced Business Certificate, Healthcare Finance, UCONN
Predoctoral Fellow, Pharmaceutical Science, AFPE
Postdoctoral Fellow, Medical Oncology, YALE
10+ peer-reviewed publications
Patent on epigenetic agents (WO2013192554A1)
Professional Summary
Dr. Sophia Nnenna Ononye-Onyia is a Nigerian-American entrepreneur and life science strategist with interests in and passion for oncology, innovative drug development, digital health and value-based care. In addition to serving as a board member and key advisor for biopharmaceutical companies, Dr. Ononye-Onyia leads the provision of fully integrated communication services for The Sophia Consulting Firm. She is also the host of the Amplifying Scientific Innovation Podcast where she features biotech CEOs, founders and senior executives with the goal of showcasing novel scientific discoveries.
A former Pfizer scientist and Yale-trained molecular oncologist, Dr. Ononye-Onyia utilizes her multidisciplinary background (PhD, MPH, MBA) to advise clients in the life science industry on value communications and strategy planning for new drug launches with a specialty focus on oncology. She is trained in hematology and oncology with demonstrated experience in epigenetics, targeted therapies, combination therapies, checkpoint inhibitors, CAR T cell therapies and other cancer immunotherapies. Sophia also has broad therapeutic experience in rare diseases, women's health, pain management, and infectious diseases.
Professional Affiliations
Host, Amplifying Scientific Innovation Podcast
Entrepreneur-in-Residence, YALE
Key Advisor, BioSortia Pharmaceuticals
Expert Advisory Board (EAB) Member, Catalant
Board Member, BlueCloud by HealthCarePoint
Member, Massachusetts Biotechnology Council (MASSBIO)
Woman of The Week (WoW) Podcast Guest, PharmaVoice
Guest Contributor & Host, Pharmacy Podcast Network
Venture Partner, FundRx
Advisor, Harvard Biomedical Careers Science Program
Editorial Advisory Board Member, Cell & Gene
Panelist, MIT Technology Review
Contributor, Life Science Leader
Contributor, PharmaBoardRoom
Member, NYC Health Business Leaders
Mentor, Healthcare Businesswomen Association (HBA)
Spark Awardee, HBA
Certificate of Congressional Recognition, 30 Black Stars Award
Advisory Team
Ellen Wingard
Loraine Upham, M.B.A.
James Boyle, Ph.D.
LEADERSHIP CONSULTANT
Ms. Ellen Wingard is an early innovator in the field of leadership development and has for 30 years coached and advised CEOs and emerging leaders in health care, financial services, consumer goods, pharmaceuticals, technology and higher education. She is co-author of Enlightened Leadership: How Women are Transformin
LEADERSHIP CONSULTANT
Ms. Ellen Wingard is an early innovator in the field of leadership development and has for 30 years coached and advised CEOs and emerging leaders in health care, financial services, consumer goods, pharmaceuticals, technology and higher education. She is co-author of Enlightened Leadership: How Women are Transforming the Practice of Leadership. She is past Board Chair of World Pulse Media, an media channel linking 50,000 grassroots leaders across 190 countries, and a member of the Women’s Leadership Board at Harvard Kennedy School, where she engages with 150 top global corporate leaders on the latest practices in global talent development, gender inclusion and socially responsible business. She is part of the Executive Coaching pool of the Harvard Business School Executive Education Program and has been a commentator on career navigation and intergenerational mentoring to the Committee of 200, the Fletcher School International Business Program, Harvard Kennedy School, and NPR Marketplace. She has also served as a Mentor for the Impact Center a program affiliated with the Federal Leadership Program for distinguished public sector women leaders.
James Boyle, Ph.D.
Loraine Upham, M.B.A.
James Boyle, Ph.D.
ALLIANCE MANAGEMENT STRATEGIST
Dr. James (Jim) Boyle is a co-founder and the Managing Director of the Yale Entrepreneurial Institute (YEI), a business/educational unit within Yale University that was formed with the mission of mentoring students with new venture ideas and that has expanded to include the development of faculty ventures. Pr
ALLIANCE MANAGEMENT STRATEGIST
Dr. James (Jim) Boyle is a co-founder and the Managing Director of the Yale Entrepreneurial Institute (YEI), a business/educational unit within Yale University that was formed with the mission of mentoring students with new venture ideas and that has expanded to include the development of faculty ventures. Prior to forming YEI, Jim was responsible within the Office of Cooperative Research (OCR) for the licensing and venture startup of a number of engineering-based technologies. Before joining OCR, he developed and actively managed the University’s largest corporate research alliance, managing a large array of both Yale and external scientists in bioimaging-based collaborations. Earlier, Jim co-founded and grew a predictive analytics consulting practice, providing both technical and pricing guidance on new product development to a wide array of Fortune 1000 companies in the scientific equipment industry. Jim began his entrepreneurial career while still a Yale graduate student, developing novel instruments for characterizing trace biomolecules with the support of the National Institutes of Health, and later commercializing these devices through a wide array of OEM partnerships as part of a Yale startup.
Loraine Upham, M.B.A.
Loraine Upham, M.B.A.
Loraine Upham, M.B.A.
BIOTECH COMMERCIAL STRATEGIST
Ms. Loraine Upham's 30-year career in biotechnology and business ranges from basic research in the Molecular Genetics Research Laboratories at Eli Lilly and Company, to design and marketing of nuclear and fluorescence detection instrumentation at Packard BioScience (now Perkin Elmer), to process and business
BIOTECH COMMERCIAL STRATEGIST
Ms. Loraine Upham's 30-year career in biotechnology and business ranges from basic research in the Molecular Genetics Research Laboratories at Eli Lilly and Company, to design and marketing of nuclear and fluorescence detection instrumentation at Packard BioScience (now Perkin Elmer), to process and business development at a proteomic start up, Prolexys. In 2005, she co-founded CureDM, Inc. together with two endocrinologists, to develop a novel diabetes treatment which she co-invented; as founding CEO of CureDM, she successfully obtained over $5M in financing and engineered partnerships to conduct basic research and establish the proof of concept for the diabetes drug which is now Phase II ready. Lori received a B.A. in Biology from University of Pennsylvania and an M.B.A from Arizona State University. She is a board member of numerous biotech companies and participates on the Investment Committee of the ABQid/CNM Ingenuity venture fund.
Our Partners
